Strong Q1 performance — best in 5 years
Group revenues of almost EUR 2.0 billion with organic growth of +2% year‑on‑year; order intake remained solid at >EUR 2.2 billion (only slightly down year‑on‑year). Management described this as the best first quarter in the past 5 years.
Material improvement in profitability (group level)
Operating EBIT margin increased by 140 basis points year‑on‑year to the highest Q1 level in 5 years (management highlighted strong aftermarket, operating leverage and BOOST efficiency benefits).
CVS (Truck) margin recovery and earnings step‑up
CVS revenues EUR 878 million with organic growth of +3.6% year‑on‑year. Operating EBIT for CVS reached EUR 101 million and EBIT margin improved to 11.5% (+200 bps year‑on‑year). Full‑year target: CVS margin towards 12%.
RVS (Rail) backlog and order momentum
RVS order intake EUR 1.26 billion, book‑to‑bill ~1.2, and order backlog increased +7% to >EUR 5.9 billion (record level), providing a solid foundation for 2026 and beyond.
Cash generation and capital efficiency improved
Free cash flow improved to EUR 32 million in Q1 (versus EUR 15 million prior year quarter, an increase of EUR 17 million). Return on capital employed rose to 21%. Net working capital decreased to EUR 1.46 billion and scope of days reduced by ~4 days. Capex was EUR 62 million (moderate increase).
Strategic progress — BOOST program and M&A
BOOST cost and efficiency measures continue to contribute to margin recovery; management announced a new program (growth + efficiency) to be detailed in July. Recent duagon acquisition was integrated into Q1 results (management expects duagon to reach ~16% EBIT margin over time) and North American signaling assets have delivered >18% returns.
Confirmed full‑year guidance
Management reconfirmed 2026 guidance: revenues EUR 8.0–8.3 billion, operating margin of at least 14%, and free cash flow EUR 750–850 million (assumes geopolitics and FX remain broadly stable).